Ya-Yu Chen1,2, Chia-Fang Tsai3, Ming-Chu Tsai3, Wen-Kang Chen4, Yu-Wen Hsu2, Fung-Jou Lu1,5. 1. Institute of Medicine, College of Medicine, Chung Shan Medical University, Taichung City 40201, Taiwan, China. 2. Department of Optometry, Da-Yeh University, Changhua 51591, Taiwan, China. 3. Department of Biotechnology, TransWorld University, Douliu City 64063, Taiwan, China. 4. Department of Applied Cosmetology, Tainan Junior College of Nursing, Tainan City 70043, Taiwan, China. 5. Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung City 40201, Taiwan, China.
Abstract
AIM: To investigate the anti-fibrosis effect of rosmarinic acid (RA) in pterygium epithelial cells (PECs) to determine if RA is a potent agent for treating pterygium. METHODS: The PECs (1×104 cells/mL) were treated with 100 µmol/L of RA for 1, 3 and 6h. After RA treatment, the cell viability was determined by staining with acridine orange/DAPI and analysis via a NucleoCounter NC-3000. The protein expression levels of type I collagen, transforming growth factor beta-1 (TGF-β1), TGF-β type II receptor (TGF-βRII), p-Smad1/5, p-Smad2, p-Smad3, and Smad4 of the cell lysates were measured by Western blot analysis. RESULTS: The cell viability of PECs was significantly decreased after RA treatment (P<0.01). As the result, RA reduced the protein expression of type I collagen and TGF-β1 of PECs. Additionally, RA also inhibited TGF-β1/Smad signaling by decreasing the protein expressions of TGF-βRII, p-Smad1/5, p-Smad2, p-Smad3, and Smad4. CONCLUSION: This study demonstrate that RA could inhibit fibrosis of PECs by down-regulating type I collagen expression and TGF-β1/Smad signaling. Therefore, RA is a potent therapeutic agent for the treatment of pterygium.
AIM: To investigate the anti-fibrosis effect of rosmarinic acid (RA) in pterygium epithelial cells (PECs) to determine if RA is a potent agent for treating pterygium. METHODS: The PECs (1×104 cells/mL) were treated with 100 µmol/L of RA for 1, 3 and 6h. After RA treatment, the cell viability was determined by staining with acridine orange/DAPI and analysis via a NucleoCounter NC-3000. The protein expression levels of type I collagen, transforming growth factor beta-1 (TGF-β1), TGF-β type II receptor (TGF-βRII), p-Smad1/5, p-Smad2, p-Smad3, and Smad4 of the cell lysates were measured by Western blot analysis. RESULTS: The cell viability of PECs was significantly decreased after RA treatment (P<0.01). As the result, RA reduced the protein expression of type I collagen and TGF-β1 of PECs. Additionally, RA also inhibited TGF-β1/Smad signaling by decreasing the protein expressions of TGF-βRII, p-Smad1/5, p-Smad2, p-Smad3, and Smad4. CONCLUSION: This study demonstrate that RA could inhibit fibrosis of PECs by down-regulating type I collagen expression and TGF-β1/Smad signaling. Therefore, RA is a potent therapeutic agent for the treatment of pterygium.
Entities:
Keywords:
fibrosis; pterygium; rosmarinic acid; transforming growth factor beta-1; type I collagen
Authors: Cristina P R Xavier; Cristovao F Lima; Manuel Fernandes-Ferreira; Cristina Pereira-Wilson Journal: Nutr Cancer Date: 2009 Impact factor: 2.900
Authors: Li-Fong Seet; Li Zhen Toh; Sharon N Finger; Stephanie W L Chu; Branko Stefanovic; Tina T Wong Journal: J Mol Med (Berl) Date: 2015-10-27 Impact factor: 4.599